Edge Therapeutics, Inc. Business Finance Contracts & Agreements

26 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Share Transfer Agreement by and between PDS Biotechnology Corporation and Merck KGaA, Darmstadt, Germany
Share Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2023
Venture Loan and Security Agreement, dated August 24, 2022, by and among Horizon Technology Finance Corporation, as a lender and collateral agent, Powerscourt Investments XXV, LP,...
Loan Agreements
Edge Therapeutics, Inc.
Biotechnology
CT
2022
Form of Warrant issued under the Venture Loan and Security Agreement, dated August 24, 2022
Loan Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2022
Underwriting Agreement, dated June 15, 2021, by and among PDS Biotechnology Corporation and Cantor Fitzgerald & Co
Underwriting Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2021
Underwriting Agreement dated August 11, 2020
Underwriting Agreements
Edge Therapeutics, Inc.
Biotechnology
2020
Form of Underwriting Agreement
Underwriting Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2020
Common Stock Purchase Agreement, dated July 29, 2019 between PDS Biotechnology Corporation and Aspire Capital Fund, LLC
Stock Agreements
Edge Therapeutics, Inc.
Biotechnology
IL
2019
Registration Rights Agreement, dated July 29, 2019, between PDS Biotechnology Corporation and Aspire Capital Fund, LLC
Registration Rights Agreements
Edge Therapeutics, Inc.
Biotechnology
IL
2019
Form of Stock Option Grant Notice and Stock Option Agreement under the 2019 Inducement Plan
Stock Agreements
Edge Therapeutics, Inc.
Biotechnology
2019
Form of Subscription Agreement dated April 19, 2017, between Edge Therapeutics, Inc. and certain investors
Subscription Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2017
Form of Employee Stock Option Agreement
Stock Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2017
Form of Executive Stock Option Agreement
Stock Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2017
Amended and Restated Loan and Security Agreement, dated as of August 1, 2016, by and between the Company and Hercules Capital, Inc
Loan Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2016
Warrant to Purchase 18,000 Shares of Common Stock issued to Maxim Partners LLC, dated as of October 6, 2015
Warrant Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2015
CONFIDENTIAL MATERIAL OMITTED AND FILEDSEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. DOUBLE ASTERISKS DENOTE SUCH OMISSIONS. AMENDMENT NO. 1 TO THE LICENSE AGREEMENT
Exchange Agreements
Edge Therapeutics, Inc.
Biotechnology
2015
EDGE THERAPEUTICS, INC. Common Stock, par value $0.00033 pershare UNDERWRITING AGREEMENT
Underwriting Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2015
AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Edge Therapeutics, Inc.
Biotechnology
2015
LOAN ANDSECURITY AGREEMENT
Loan Agreements
Edge Therapeutics, Inc.
Biotechnology
CA
2015
CONFIDENTIAL MATERIALOMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. DOUBLE ASTERISKSDENOTE SUCH OMISSIONS. LICENSE AGREEMENT
Exchange Agreements
Edge Therapeutics, Inc.
Biotechnology
NJ
2015
INVESTORSRIGHTS AGREEMENT byand among EdgeTherapeutics, Inc., VenrockHealthcare Capital Partners II, L.P., and theother Investors named herein April6, 2015
Investor Rights Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2015
EDGE THERAPEUTICS, INC. Preferred Stock Warrant
Warrant Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2015
WARRANT AGREEMENT To Purchase Shares of Preferred Stock of EDGE THERAPEUTICS, INC. Dated as of August28, 2014 (the Effective Date)
Warrant Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2015
EDGE THERAPEUTICS, INC. Preferred Stock Warrant
Warrant Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2015
EDGE THERAPEUTICS, INC. WARRANT TO PURCHASE [______] SHARES OF COMMON STOCK
Warrant Agreements
Edge Therapeutics, Inc.
Biotechnology
NJ
2015
FIRST AMENDMENT TO WARRANT NO. 1
Warrant Agreements
Edge Therapeutics, Inc.
Biotechnology
2015
EDGE THERAPEUTICS, INC. WARRANT TO PURCHASE 16,667 SHARES OF CAPITAL STOCK
Warrant Agreements
Edge Therapeutics, Inc.
Biotechnology
NJ
2015